Episode 207: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner
Who's going to run Biogen? Does Aduhelm have a future? And is it OK to shame reporters? This week, we delve into Biogen's twin announcements that the company is pulling the plug on Aduhelm and replaci...
5 Mai 202231min
Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum
Can rewired cells cure some patients' cancer? Do biotech stocks ever go up? And why's it taking so long to get kids vaccinated for Covid-19? Immunologist Katy Rezvani of MD Anderson Cancer Center join...
28 Apr 202229min
Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices
Can buyouts be bad news? Why can't Novavax meet a deadline? And what does "breakthrough" actually mean? First, we delve into why the latest big biotech acquisition has ominous implications for the dow...
21 Apr 202232min
Episode 204: Leana Wen on the pandemic's new normal and whether Twitter is real life
Are we supposed to just get used to superspreader events? What's going with Editas Medicine? And why are people on Twitter so angry? Leana Wen, an emergency medicine physician and public health profe...
14 Apr 202238min
Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success
What's on tap for Roche and its closely followed cancer immunotherapy? Are we all headed for another jab with a Covid-19 vaccine? And what explains the recent success of Vertex Pharmaceuticals' R&D pi...
7 Apr 202233min
Introducing: Color Code
As long as there's been a medical system, it's been one that is rife with instances of mistreatment — both on the individual and community levels — that have harmful effects on how Black Americans vie...
31 Mar 202229min
Episode 202: Helen Branswell on the pandemic, plus the next FDA debate & the perks of being a CEO
Are Covid-19 vaccines a sustainable business? Was Aduhelm an aberration? And what comes after Omicron? Senior writer Helen Branswell joins us to discuss the latest twists in the pandemic, including r...
24 Mar 202235min
Episode 201: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas
How should pharma treat Russia? Why can't Congress pass a drug pricing bill? And what does wastewater portend for the pandemic? First, we discuss the drug industry's response to Russia's invasion of ...
17 Mar 202231min
